Syndax Pharmaceutica
SNDX
Delayed Nasdaq - 04/20 10:00:00 pm
11.03USD
+1.57%
Upcoming events
05/14/18
Q1 2018 Earnings Release (Projected)
05/23/18
Annual General Meeting
08/08/18
Interim 2018 Earnings Release (Projected)
11/07/18
Q3 2018 Earnings Release (Projected)
Past Events
04/14/18American Association for Cancer Research Meeting
03/21/18 | 07:45pmOppenheimer Healthcare Conference
03/12/18 | 09:10pmCowen & Co. Health Care Conference
03/05/18 | 10:30pmFY 2017 Earnings Call
Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
2,11
2,19
-3,7%

2,01
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-61,9
-62,5
0,92%

-89,8
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-62,0
-61,2
-1,2%

-90,8
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-60,8
-60,0
-1,4%

-86,1
Net income
Million $
Released
Forecast
Spread
-60,8
-60,0
-1,4%

-89,6
EPS
 $
Released
Forecast
Spread
-2,90
-2,88
-0,69%

-3,55
Announcement Date03/05/2018
Quarterly / Semiannualy publications
Quarterly resultsQ4
2017
Q1
2018 (e)
Sales
Million $
Released
Forecast
Spread
1,19
1,65
-28%

0,48
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-19,5
-19,1
-1,9%

-22,9
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-19,1
-18,8
-1,8%

-22,6
Net income
Million $
Released
Forecast
Spread
-19,1
-18,8
-1,8%

-22,6
EPS
 $
Released
Forecast
Spread
-0,80
-0,80
-0,41%

-0,96
Announcement Date03/05/2018